Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. It is particularly valuable in the development of potential therapeutic agents targeting neurological disorders, such as depression and anxiety, due to its structural similarity to compounds that interact with serotonin receptors. Additionally, it is explored for its potential in creating novel antidepressants and anxiolytics, leveraging its cyclopropylamine moiety, which is known to influence neurotransmitter systems. Its application extends to chemical biology studies, where it aids in understanding receptor-ligand interactions and drug design.